Search research articles
Contact Us
Filters
Showing results (41-50 of 45) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 45 results.
Breast Cancer Research and Treatment
|
November 30, 2010
Acquisition of metastatic tissue from patients with bone metastases from breast cancer
J F Hilton, E Amir, S Hopkins, et al.
Musculoskeletal Care
|
December 9, 2017
The feasibility and acceptability of a physical activity intervention for older people with chronic musculoskeletal pain: The iPOPP pilot trial protocol
E L Healey, C Jinks, N E Foster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 13, 2020
Phase III randomized study of taselisib or placebo with fulvestrant in estrogen receptor-positive, PIK3CA-mutant, HER2-negative, advanced breast cancer: the SANDPIPER trial
S Dent, J Cortés, Y-H Im, et al.
ESMO Open
|
January 21, 2023
Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial
E de Azambuja, E Agostinetto, M Procter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2020
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
G Curigliano, D Lenihan, M Fradley, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 45) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 45 results.
Breast Cancer Research and Treatment
|
November 30, 2010
Acquisition of metastatic tissue from patients with bone metastases from breast cancer
J F Hilton, E Amir, S Hopkins, et al.
Musculoskeletal Care
|
December 9, 2017
The feasibility and acceptability of a physical activity intervention for older people with chronic musculoskeletal pain: The iPOPP pilot trial protocol
E L Healey, C Jinks, N E Foster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 13, 2020
Phase III randomized study of taselisib or placebo with fulvestrant in estrogen receptor-positive, PIK3CA-mutant, HER2-negative, advanced breast cancer: the SANDPIPER trial
S Dent, J Cortés, Y-H Im, et al.
ESMO Open
|
January 21, 2023
Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial
E de Azambuja, E Agostinetto, M Procter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2020
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
G Curigliano, D Lenihan, M Fradley, et al.
Page
of 5